{"id":"https://openalex.org/W69654598","doi":null,"title":"Addictive potential of Tianeptine - the threatening reality.","display_name":"Addictive potential of Tianeptine - the threatening reality.","publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W69654598","mag":"69654598","pmid":"https://pubmed.ncbi.nlm.nih.gov/19801742"},"language":"en","primary_location":{"id":"pmid:19801742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19801742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Georgian medical news","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053304457","display_name":"D Vadachkoria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7848551","display_name":"Tbilisi State Medical University","ror":"https://ror.org/020jbrt22","country_code":"GE","type":"education","lineage":["https://openalex.org/I7848551"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"D Vadachkoria","raw_affiliation_strings":["Scientific-Research Institute of Addiction, Tbilisi State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific-Research Institute of Addiction, Tbilisi State Medical University","institution_ids":["https://openalex.org/I7848551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072132622","display_name":"Luiza Gabunia","orcid":"https://orcid.org/0000-0003-0856-2684","observed_orcids":["https://orcid.org/0000-0003-0856-2684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Gabunia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057098647","display_name":"K Gambashidze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Gambashidze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003104784","display_name":"N Pkhaladze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Pkhaladze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073221133","display_name":"Nika Kuridze","orcid":"https://orcid.org/0000-0002-2586-7909","observed_orcids":["https://orcid.org/0000-0002-2586-7909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Kuridze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":null,"issue":"174","first_page":"92","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.32030001282691956,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.32030001282691956,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.24379999935626984,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.22390000522136688,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tianeptine","display_name":"tianeptine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.8640000224113464},{"id":"https://openalex.org/keywords/opiate-users","display_name":"opiate users","score":0.5090000033378601},{"id":"https://openalex.org/keywords/withdrawal-syndrome","display_name":"withdrawal syndrome","score":0.7910000085830688},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.9190000295639038},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.7360000014305115},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9860000014305115},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8640000224113464},{"id":"https://openalex.org/keywords/locus-coeruleus","display_name":"locus coeruleus","score":0.9739999771118164}],"concepts":[{"id":"https://openalex.org/C2776903192","wikidata":"https://www.wikidata.org/wiki/Q424260","display_name":"Tianeptine","level":4,"score":0.9679534435272217},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.734743595123291},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5711857676506042},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.4602670967578888},{"id":"https://openalex.org/C2778941446","wikidata":"https://www.wikidata.org/wiki/Q545365","display_name":"Anhedonia","level":3,"score":0.4539979100227356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4510497450828552},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.44685298204421997},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4446474313735962},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.44140610098838806},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3706306219100952},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.36344674229621887},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27283135056495667},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13438016176223755},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D005059","descriptor_name":"Euphoria","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D013841","descriptor_name":"Thiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013841","descriptor_name":"Thiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19801742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19801742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Georgian medical news","raw_type":"Journal Article"},{"id":"mag:69654598","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19801742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W79342395","https://openalex.org/W2189202907","https://openalex.org/W7220758950","https://openalex.org/W1964720381","https://openalex.org/W65114149","https://openalex.org/W7128433781","https://openalex.org/W2040725032","https://openalex.org/W2465416172","https://openalex.org/W7160936395","https://openalex.org/W7098357862"],"abstract_inverted_index":{"A":[0],"total":[1],"of":[2,8,25,46,74,86,92,95,101,111,116,123,150,161,166,177],"24":[3],"patients":[4,26],"(male":[5],"volunteers),":[6],"consumers":[7],"opiates":[9,104,129],"in":[10,61,109,113,143,153,184,188,204],"the":[11,41,56,72,114,178,192],"past":[12],"and":[13,77,88,103,125,139,169,187],"suffering":[14],"from":[15,28],"Tianeptine":[16,33,60,102,201],"abuse,":[17],"were":[18],"under":[19],"clinical":[20],"observation.":[21],"The":[22,43],"age":[23],"range":[24],"was":[27,36,48,68],"21":[29],"to":[30,145],"33":[31],"years.":[32],"consumption":[34,105,130],"history":[35],"5":[37],"months":[38],"duration":[39],"on":[40,55],"average.":[42],"daily":[44],"dose":[45],"preparation":[47],"40":[49],"tablets":[50],"(500":[51],"mg":[52],"intravenous":[53],"injections":[54],"average).":[57],"Patients":[58],"used":[59,82],"combination":[62],"with":[63,71],"antihistamines":[64],"(Promethazine,":[65],"Suprastin).":[66],"Research":[67],"carried":[69],"out":[70],"use":[73],"clinical,":[75],"psychological":[76],"laboratory":[78],"methods.":[79],"Has":[80],"been":[81,212],"Ch.":[83],"Spilberger's":[84],"scale":[85,91],"anxiety":[87,124],"T.":[89],"Balashov's":[90],"depression.":[93],"Comparison":[94],"withdrawal":[96,117,132],"syndrome":[97,118,133],"developed":[98],"after":[99],"cessation":[100],"has":[106,211],"shown":[107],"that":[108,156,197],"case":[110],"Tianeptine,":[112,142],"dynamic":[115],"predominates":[119],"well":[120],"expressed":[121],"high-level":[122],"depression,":[126],"while":[127],"at":[128,200],"-":[131],"is":[134],"characterized":[135],"by":[136,175],"algesic":[137],"events":[138],"vegetodysfunctions.":[140],"Supposedly,":[141],"contrast":[144],"other":[146],"anti-depressants,":[147],"stimulates":[148],"release":[149],"neurotransmitter":[151],"dopamine":[152],"nucleus":[154],"Accumbens,":[155],"probably":[157],"determine":[158],"addictive":[159],"potential":[160,195],"this":[162],"drug.":[163],"High":[164],"level":[165],"anxiety,":[167],"excitability":[168],"vegetodysfunctions,":[170],"presumably":[171],"could":[172],"be":[173],"explained":[174],"activation":[176],"NMDA":[179],"(glutamate":[180],"receptors)":[181],"receptor":[182],"system":[183],"Locus":[185],"coeruleus,":[186],"vegetative":[189],"ganglion.":[190],"In":[191],"present":[193],"article":[194],"threat":[196],"may":[198],"develop":[199],"consumption,":[202],"especially":[203],"former":[205],"opiate":[206],"consumers,":[207],"without":[208],"medical":[209],"purposes":[210],"emphasized.":[213]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}